RAMB - MAIO 2017

94 / 96

Vieira RAC et al.
474 Rev Assoc Med Bras 2017; 63(5):466-475
11. Oliveira EX, Melo EC, Pinheiro RS, Noronha CP, Carvalho MS. [Access to
cancer care: mapping hospital admissions and high-complexity outpatient
care flows. The case of breast cancer]. Cad Saúde Pública. 2011; 27(2):317-26.
12. Martins CHF. Ambiente de informações para apoio à decisão dos gestores
do controle do câncer de mama [dissertation]. Rio de Janeiro: Fundação
Oswaldo Cruz; 2009.
13. Passman LJ, Farias AM, Tomazelli JG, de Abreu DM, Dias MB, de Assis M,
et al. SISMAMA – implementation of an information system for breast
cancer early detection programs in Brazil. Breast. 2011; 20(Suppl 2):S35-9.
14. Azevedo e Silva G, Bustamante-Teixeira MT, Aquino EM, Tomazelli JG, Dos-
Santos-Silva I. [Access to early breast cancer diagnosis in the Brazilian Unified
National Health System: an analysis of data from the Health Information
System]. Cad Saúde Pública. 2014; 30(7):1537-50.
15. Correa RS, Freitas-Junior R, Peixoto JE, Rodrigues DC, Lemos ME, Marins
LA, et al. [Estimated mammogram coverage in Goias State, Brazil]. Cad
Saúde Pública. 2011; 27(9):1757-67.
16. Corrêa RS, Freitas-Junior R, Peixoto JE, Rodrigues DC, Lemos ME, Dias CM,
et al. Effectiveness of a quality control program in mammography for the
Brazilian National Health System. Rev Saúde Pública. 2012; 46(5):769-76.
17. Amorim VM, Barros MB, César CL, Carandina L, Goldbaum M. [Factors
associated with lack of mammograms and clinical breast examination by
women: a population-based study in Campinas, Sao Paulo State, Brazil].
Cad Saúde Pública. 2008; 24(11):2623-32.
18. Lages RB, Oliveira GP, Simeão Filho VM, Nogueira FM, Teles JB, Vieira SC.
Inequalities associated with lack of mammography in Teresina-Piauí-Brazil,
2010-2011. Rev Bras Epidemiol. 2012; 15(4):737-47.
19. Marchi AA, Gurgel MS. [Adherence to the opportunistic mammography
screening in public and private health systems]. Rev Bras Ginecol Obstet.
2010; 32(4):191-7.
20. Caetano S, Mottola Junior J, Finguerman F, Goldman SM, Szejnfeld J.
Mammographic assessment of a geographically defined population at a
mastology referral hospital in São Paulo Brazil. PloS One. 2013; 8(9):e74270.
21. Ribeiro RA, Caleffi M, Polanczyk CA. [Cost-effectiveness of an organized
breast cancer screening program in Southern Brazil]. Cad Saúde Pública.
2013; 29(Suppl 1):S131-45.
22. Marconato RR, Soarez PC, Ciconelli RM. [Costs of mammogram campaigns
in the Regional Health Division of Marília, São Paulo State, Brazil, 2005-
2006]. Cad Saúde Pública. 2011; 27(8):1529-36.
23. Gravena AA, Brischiliari SC, Gil LM, Lopes TC, Demitto Mde O, Agnolo
CM, et al. Years of potential life lost due to breast and cervical cancer: a
challenge for Brazilian public policy. Asian Pac J Cancer Prev. 2014;
15(23):10313-7.
24. Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LN. Difficulties in
implementing an organized screening program for breast cancer in Brazil
with emphasis on diagnostic methods. Rural Remote Health. 2013; 13(2):2321.
25. Medeiros GC, Bergmann A, Aguiar SS, Thuler LC. [Determinants of the
time between breast cancer diagnosis and initiation of treatment in Brazilian
women]. Cad Saúde Pública. 2015; 31(6):1269-82.
26. Freitas AG, Weller M. Patient delays and system delays in breast cancer
treatment in developed and developing countries. Ciênc Saúde Coletiva.
2015; 20(10):3177-89.
27. Balabram D, Turra CM, Gobbi H. Survival of patients with operable breast
cancer (Stages I-III) at a Brazilian public hospital – a closer look into cause-
specific mortality. BMC Cancer. 2013; 13:434.
28. Guerra MR, Azevedo e Silva G, Nogueira MC, Leite IC, Oliveira RV, Cintra
JR, et al. Breast cancer survival and health iniquities. Cad Saúde Pública.
2015; 31(8):1673-84.
29. Bello MA. Análise estatística da mortalidade por câncer de mama feminina
no estado do Rio de Janeiro, 2001 a 2006 [dissertation]. Rio de Janeiro:
Fundação Oswaldo Cruz; 2010.
30. Brito C, Portela MC, Vasconcellos MT. [Survival of breast cancer women in
the state of Rio de Janeiro, Southeastern Brazil]. Rev Saúde Pública. 2009;
43(3):481-9.
31. Gonçalves ATC, Jobim PFC, Vanacor R, Nunes LN, Albuquerque IMd, Bozzetti
MC. Câncer de mama: mortalidade crescente na Região Sul do Brasil entre
1980 e 2002. Cad Saúde Pública. 2007; 23(8):1785-90.
32. Kluthcovsky AC, Faria TN, Carneiro FH, Strona R. Female breast cancer
mortality in Brazil and its regions. Rev Assoc Med Bras. 2014; 60(4):387-93.
33. Freitas-Junior R, Gonzaga CM, Freitas NM, Martins E, Dardes RC. Disparities
in female breast cancer mortality rates in Brazil between 1980 and 2009.
Clinics. 2012; 67(7):731-7.
34. Vieira RA, Uemura G, Zucca-Matthes G, Costa AM, Micheli RA, Oliveira
CZ. Evaluating breast cancer health system between countries: the use
of USA/SEER and Brazilian women as a cohort sample. Breast J. 2015;
21(3):322-3.
35. Gøtzsche PC, Jøtrgensen KJ. Screening for breast cancer with mammography.
Cochrane Database Syst Rev. 2013; 6:CD001877.
36. Bleyer A. Were our estimates of overdiagnosis with mammography screening
in the United States “based on faulty science”? Oncologist. 2014; 19(2):113-26.
37. Kopans DB. Arguments against mammography screening continue to be
based on faulty science. Oncologist. 2014; 19(2):107-12.
38. Vieira RAM, Mauad EC, Matheus AGZ, Haikel Jr. RL, Mattos JSC, Bauab
SP. Rastreamento mamográfico: começo-meio-fim. Rev Bras Mastol. 2010;
20(2):92-7.
39. Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent
J, et al. Cancer screening in the United States, 2016: a review of current
American Cancer Society guidelines and current issues in cancer screening.
CA Cancer J Clin. 2016; 66(2):95-114.
40. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L.
European guidelines for quality assurance in breast cancer screening and
diagnosis. Fourth edition--summary document. Ann Oncol. 2008;
19(4):614-22.
41. Yaffe MJ, Pritchard KI. Overdiagnosing overdiagnosis. Oncologist. 2014;
19(2):103-6.
42. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V,
Bianchini F, et al. Breast-cancer screening--viewpoint of the IARC Working
Group. N Engl J Med. 2015; 372(24):2353-8.
43. Lima-Costa MF, Matos DL. [Prevalence and factors associated with
mammograms in the 50-69-year age group: a study based on the Brazilian
National Household Sample Survey (PNAD-2003)]. Cad Saúde Pública.
2007; 23(7):1665-73.
44. De Castro Mattos JS, Mauad EC, Syrjänen K, Longatto-Filho A, Haikel RL,
Da Costa Vieira RA, et al. The impact of breast cancer screening among
younger women in the Barretos Region, Brazil. Anticancer Res. 2013;
33(6):2651-5.
45. Akhlaq A, McKinstry B, Muhammad KB, Sheikh A. Barriers and facilitators
to health information exchange in low- and middle-income country settings:
a systematic review. Health Policy Plan. 2016; 31(9)1310-25.